Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female adults~* Presence of an active exacerbation of the ongoing COPD requiring hospitalization for treatment~* Subjects with a documented diagnosis of COPD C or D~* Current smokers or ex-smokers~* A documented history of at least one moderate or severe COPD exacerbation in the 12 months preceding the Screening Visit that required antibiotics and/or systemic corticosteroid.~* Current regular treatment for COPD (for at least 2 months prior to the Screening Visit.~Exclusion Criteria:~* Age less than 40 years old~* Current diagnosis of asthma~* Subjects who have already completed treatment for the current exacerbation of COPD~* Subjects currently requiring intensive care unit (ICU) and/or mechanical ventilation~* Received a course of PDE4, p38 or PDE3/4 inhibitors within their respective defined washout periods.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Regimen 1 (Type: EXPERIMENTAL): Drug: BCT197 Dose 1, Day 1 to Day 5
- Regimen 2 (Type: EXPERIMENTAL): Drug: BCT197 Dose 2, Day 1 to Day 5
- Regimen 3 (Type: PLACEBO_COMPARATOR): Placebo Day 1 to Day 5

Based on this trial design, predict the completion outcome and termination type (if applicable).